Navigation Links
U.K.: Justice for Asbestos Disease Victims Requires Mesothelioma Research Funding
Date:3/5/2010

The U.K. recognizes that society’s obligation and moral responsibility to remedy the tragic legacy of decades of asbestos use requires funding research to develop effective medical treatments. Will the United States follow?

(PRWEB) March 5, 2010 -- The Mesothelioma Applied Research Foundation today publicly praised the United Kingdom’s Ministry of Justice for its progressive and constructive new position on asbestos disease.

Last week, the U.K.’s Minister of Justice, Jack Straw, announced that, along with the vast legal aspects of the asbestos cancer, mesothelioma, the government has an obligation to also address its medical aspects. With this announcement, the U.K. recognizes that the industrial legacy of asbestos, from which all of society has benefited, creates an obligation on the part of society and the government to help those who now bear the burden -- suffering and loss of life from asbestos-caused disease.

Therefore the U.K. government has committed to support a “National Centre for Asbestos-Related Disease, a collaborative network of funded researchers whose core purpose would be to advance medical research into the prevention, cure and alleviation of asbestos-related disease and primarily mesothelioma.”

Not only would development of effective mesothelioma treatments serve justice, it would also significantly reduce the costs of litigation, death and disability benefits, and healthcare. Recognizing this, the U.K. insurance industry has also pledged £3 million towards the National Centre for Asbestos-Related Disease.

“This is exactly what the Mesothelioma Applied Research Foundation has been urging in the United States the past ten years,” says Christopher Hahn, the Foundation’s executive director. “Mesothelioma and other asbestos related diseases are a fundamental problem of social justice. And a just solution to that problem requires medical research to develop effective treatments to end the suffering and save lives. It is encouraging to see that the U.K. is getting it; we hope the U.S. will catch up soon.”

Mesothelioma is a malignant tumor of the lining of the lung, abdomen or heart caused by asbestos. Medical experts consider it one of the most aggressive of all cancers. For decades it was regarded as untreatable, deadly and hopeless; and so, in a sad, self-fulfilling prophecy, the need for research to develop effective treatments was mostly ignored. For the Mesothelioma Applied Research Foundation and today’s patients, their families, and the millions of Americans who in the last five decades have been exposed to asbestos and are at risk for the cancer, this is unacceptable. The Foundation believes in a cure for mesothelioma, and is committed to funding the research critically-needed to understand and improve treatment of it.

In addition, the Mesothelioma Applied Research Foundation provides patients and families with the most up-to-date information on mesothelioma treatments, clinical trials and medical referrals. The Foundation hosts the annual International Symposium on Malignant Mesothelioma, which unites doctors, researchers, patients and families, legal advocates, interested pharmaceutical companies, union representatives and other concerned individuals to share information and advance meso research. The Foundation also leads the effort in Washington, D.C. to gain federal investment in mesothelioma research funding and to ban the further use of asbestos. For more information visit the Mesothelioma Applied Research Foundation’s website at www.curemeso.org.

###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3689764.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Justice Department to Hold Media Event to Demonstrate New Database for Matching Unidentified Remains and Missing Persons Information
2. Medical Justice Services Inc. Joins Center for Health Transformation
3. Civil Rights and Medical Leaders Call for Social Justice in Health Care
4. Stryker Announces Resolution Related to March 2005 U.S. Department of Justice Subpoena
5. Department of Justice Awards $59M Task Order to SRA
6. Center for Health Justice Statement on Governors Veto of AB 1334
7. Susan G. Komen For The Cure, Karmanos Cancer Institute, Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Incidence and Mortality
8. Social Justice Issues Take Main Stage at Egypts National Democratic Party Convention
9. Written Statement of Kevin J. OConnor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement
10. Drugs and Injustice
11. NHCAA Presents 2007 Fraud Investigation of the Year Award to U.S. Departments of Justice, HHS, and Treasury for Convicting Internet Pharmacy Drug Kingpin
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.K.: Justice for Asbestos Disease Victims Requires Mesothelioma Research Funding 
(Date:6/28/2017)... ... June 28, 2017 , ... The parent company ... in employee engagement. Omaha-based C&A Industries, a national leader in staffing and ... in North America for 2017. The annual award, issued by Achievers, ...
(Date:6/28/2017)... ... June 28, 2017 , ... Anyone with a remote control has seen the never-ending twists on ... the flipper will get rich in no time. But what about the buyers of ... for the buyer of a flipped house. An email recently sent to Gary Case ...
(Date:6/28/2017)... ... 2017 , ... Park Systems , a leader in Atomic Force Microscopy ... attendees and Park customers on July 11, 2017 from 12-2pm at the Thirsty Bear ... CEO of Park Systems, and Prof. Krishna Saraswat , Rickey/Nielsen Professor in the ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up ... temporary lodgings for families with children receiving treatment in nearby hospitals. , Ronald ...
(Date:6/27/2017)... ... June 27, 2017 , ... Salucro, the ... the health care industry’s hospitals and provider groups, has announced that it will ... customers. Parasail Health is a San Francisco health-finance startup that has launched a ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ) today ... R. Goodwin , U.S. District Court Judge for the ... entered a case management order in MDL 2325, American ... (the "MDL") that includes a provision requiring plaintiffs in ... specific causation within one hundred twenty (120) days of ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences ... Company specializing in the development of cannabinoid-based drugs, ... a company overview at three upcoming scientific and ... Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: